NASDAQ:IRTCIrhythm Technologies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Irhythm Technologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $113.50 -1.17 (-1.02 %) (As of 07/3/2020 12:14 PM ET) Add Compare Share Today's Range$113.02Now: $113.50▼$119.6650-Day Range$109.59MA: $121.87▼$131.1852-Week Range$56.24Now: $113.50▼$136.55Volume389,229 shsAverage Volume395,627 shsMarket Capitalization$3.07 billionP/E RatioN/ADividend YieldN/ABeta1.41 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California.Read More Beat the Market (BTM) Rank™ 3.4 Analyst's Opinion Consensus RatingIrhythm Technologies has received a consensus rating of Buy. The company's average rating score is 2.88, and is based on 7 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $130.67, Irhythm Technologies has a potential upside of 15.1% from its current price of $113.50.Amount of Analyst CoverageIrhythm Technologies has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.9 Community Rank Outperform VotesIrhythm Technologies has received 323 “outperform” votes. (Add your “outperform” vote.)Underperform VotesIrhythm Technologies has received 228 “underperform” votes. (Add your “underperform” vote.)Community SentimentIrhythm Technologies has received 58.62% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Irhythm Technologies and other stocks. Vote “Outperform” if you believe IRTC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IRTC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldIrhythm Technologies does not currently pay a dividend.Dividend GrowthIrhythm Technologies does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Irhythm Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $18,902,012.00 in company stock.Percentage Held by InsidersOnly 3.10% of the stock of Irhythm Technologies is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Irhythm Technologies are expected to grow in the coming year, from ($2.24) to ($1.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Irhythm Technologies is -51.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Irhythm Technologies is -51.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIrhythm Technologies has a P/B Ratio of 22.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.4Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.39 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:IRTC Previous Symbol CUSIPN/A CIK1388658 Webwww.irhythmtech.com Phone415-632-5700Debt Debt-to-Equity Ratio0.92 Current Ratio3.60 Quick Ratio3.51Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$214.55 million Price / Sales14.30 Cash FlowN/A Price / Cash FlowN/A Book Value$5.09 per share Price / Book22.30Profitability EPS (Most Recent Fiscal Year)($2.16) Net Income$-54,570,000.00 Net Margins-24.34% Return on Equity-49.99% Return on Assets-20.40%Miscellaneous Employees748 Outstanding Shares27,040,000Market Cap$3.07 billion Next Earnings Date7/29/2020 (Estimated) OptionableOptionable NASDAQ:IRTC Rates by TradingView Receive IRTC News and Ratings via Email Sign-up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter. Irhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions How has Irhythm Technologies' stock been impacted by COVID-19 (Coronavirus)? Irhythm Technologies' stock was trading at $85.54 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, IRTC stock has increased by 32.7% and is now trading at $113.50. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Irhythm Technologies? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Irhythm Technologies in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Irhythm Technologies. When is Irhythm Technologies' next earnings date? Irhythm Technologies is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Irhythm Technologies. How were Irhythm Technologies' earnings last quarter? Irhythm Technologies Inc (NASDAQ:IRTC) announced its quarterly earnings data on Thursday, May, 7th. The company reported ($0.34) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.57) by $0.23. The firm had revenue of $63.50 million for the quarter, compared to analysts' expectations of $61.40 million. Irhythm Technologies had a negative return on equity of 49.99% and a negative net margin of 24.34%. The firm's revenue for the quarter was up 35.1% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.33) earnings per share. View Irhythm Technologies' earnings history. What guidance has Irhythm Technologies issued on next quarter's earnings? Irhythm Technologies updated its first quarter 2020 After-Hours earnings guidance on Thursday, April, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $61-62 million, compared to the consensus revenue estimate of $60.67 million. What price target have analysts set for IRTC? 8 brokers have issued 12-month price targets for Irhythm Technologies' shares. Their forecasts range from $112.00 to $142.00. On average, they anticipate Irhythm Technologies' share price to reach $130.67 in the next year. This suggests a possible upside of 15.1% from the stock's current price. View analysts' price targets for Irhythm Technologies. Has Irhythm Technologies been receiving favorable news coverage? News stories about IRTC stock have trended negative on Friday, InfoTrie reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Irhythm Technologies earned a media sentiment score of -2.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Irhythm Technologies. Who are some of Irhythm Technologies' key competitors? Some companies that are related to Irhythm Technologies include Insulet (PODD), ABIOMED (ABMD), Hill-Rom (HRC), Penumbra (PEN), Novocure (NVCR), Tandem Diabetes Care (TNDM), Globus Medical (GMED), Haemonetics (HAE), Integra Lifesciences (IART), Nevro (NVRO), ICU Medical (ICUI), Inovio Pharmaceuticals (INO), NuVasive (NUVA), Merit Medical Systems (MMSI) and Inspire Medical Systems (INSP). View all competitors. What other stocks do shareholders of Irhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Irhythm Technologies investors own include Alibaba Group (BABA), NVIDIA (NVDA), DexCom (DXCM), Paypal (PYPL), Teladoc Health (TDOC), Shopify (SHOP), Veeva Systems (VEEV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Paycom Software (PAYC). Who are Irhythm Technologies' key executives? Irhythm Technologies' management team includes the following people: Mr. Kevin M. King, Pres, CEO & Director (Age 63)Mr. Matthew C. Garrett, Chief Financial Officer (Age 51)Mr. David A. Vort, Exec. VP of Sales (Age 53)Dr. Derrick Sung, Exec. VP of Strategy & Corp. Devel. (Age 46)Mr. Karim Karti, Chief Operating Officer (Age 50) When did Irhythm Technologies IPO? (IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. What is Irhythm Technologies' stock symbol? Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC." How do I buy shares of Irhythm Technologies? Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Irhythm Technologies' stock price today? One share of IRTC stock can currently be purchased for approximately $113.50. How big of a company is Irhythm Technologies? Irhythm Technologies has a market capitalization of $3.07 billion and generates $214.55 million in revenue each year. The company earns $-54,570,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis. Irhythm Technologies employs 748 workers across the globe. What is Irhythm Technologies' official website? The official website for Irhythm Technologies is www.irhythmtech.com. How can I contact Irhythm Technologies? Irhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected] This page was last updated on 7/3/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
